Similar Articles
Effects of Tocilizumab Therapy on Serum Interleukin-33 and Interleukin-6 Levels in Patients With Rheumatoid Arthritis
In Ah CHOI, Sang Jin LEE, Won PARK, Sung Hwan PARK, Seung-cheol SHIM, Han Joo BAEK, Dae-Hyun YOO, Hyun Ah KIM, Soo Kon LEE, Yun Jong LEE, Young Eun PARK, Hoon-Suk CHA, Eun Young LEE, Eun Bong LEE, Yeong Wook SONG
DOI: 10.5606/ArchRheumatol.2018.6753
Body Mass Index and Clinical Response to Tocilizumab in Patients With Rheumatoid Arthritis
Hua HUANG, Han CEN, Li ZHOU, Ting-hui WANG, Wen QIN, Bin-hua XIE, Dong-Mei XIAO, Xiu-Di WU, Hua-Xiang WU
DOI: 10.5606/ArchRheumatol.2019.7146
Additional Benefit of Canakinumab on Proteinuria in a Case With Muckle-Wells Syndrome in Remission Under Anakinra
Ufuk İLGEN, Orhan KÜÇÜKŞAHİN
DOI: 10.5606/ArchRheumatol.2020.7378
The Turkish League Against Rheumatism Recommendations for the Management of Hand Osteoarthritis Under Guidance of the Current Literature and 2018 European League Against Rheumatism Recommendations
Fikriye Figen AYHAN, İsmihan SUNAR, Ebru UMAY, Dilek KESKİN, Lale ALTAN, Fitnat DİNÇER, Tuncay DURUÖZ, Nazım KARALEZLİ, Banu KURAN, Tiraje TUNCER
DOI: 10.46497/ArchRheumatol.2020.7693
Factors Predicting Early Failure of Etanercept in Rheumatoid Arthritis: An Analysis From the Gruppo Italiano di Studio sulla Early Arthritis (Italian Group for the Study of Early Arthritis) Registry
Marco SEBASTIANI, Andreina MANFREDI, Florenzo IANNONE, Elisa GREMESE, Alessandra BORTOLUZZI, Ennio FAVALLI, Chiara BAZZANI, Fausto SALAFFI, Enrico FUSARO, Rosario FOTI, Chiara GIANNITTI, Roberto CAPORALI, Alberto CAULI, Giulia CASSONE, Giuseppe LOPALCO, Luca PETRICCA, Gianfranco FERRACCIOLI, Giovanni LAPADULA
DOI: 10.46497/ArchRheumatol.2020.7499
Spontaneous Spinal Epidural Hematoma During Simultaneous Tocilizumab and Warfarin Use in a Patient With Rheumatoid Arthritis: Is There a Drug Interaction Between Tocilizumab and Oral Anticoagulants?
Seçilay GÜNEŞ, Haydar GÖK, Şebnem ATAMAN, Şehim KUTLAY
DOI: 10.46497/ArchRheumatol.2020.7579
Biologics in juvenile idiopathic arthritis-main advantages and major challenges: A narrative review
Amra ADROVIC, Mehmet YILDIZ, Oya KÖKER, Sezgin ŞAHİN, Kenan BARUT, Özgür KASAPÇOPUR
DOI: 10.46497/ArchRheumatol.2021.7953
SARS-CoV-2 infection in children with rheumatic disease: Experience of a tertiary referral center
Betül Sözeri, Ferhat Demir, Sevinç Kalın, Canan Hasbal Akkuş, Enes Salı, Deniz Çakır
DOI: 10.46497/ArchRheumatol.2021.8603
Incorporating patient preferences into osteoarthritis treatment
Yeşim Gökçe Kutsal, Sibel Eyigör, Sevilay Karahan, Rezzan Günaydın, Jale İrdesel, Merih Sarıdoğan, Pınar Borman, Aylin Sarı, Kutay Ordu Gökkaya, Vildan Binay Safer
DOI: 10.46497/ArchRheumatol.2022.8291
Efficacy of anakinra treatment in pediatric rheumatic diseases: Our single-center experience
Ferhat Demir, Eda Gürler, Betül Sözeri
DOI: 10.46497/ArchRheumatol.2022.8998
Evaluation of the anti-RANKL monoclonal antibody in rheumatoid arthritis rats
Dawei Lv, Xiaodong Zhao
DOI: 10.46497/ArchRheumatol.2023.9240
The impact of COVID-19 on clinical course and treatment among patients with juvenile systemic sclerosis
Amra Adrovic, Mehmet Yıldız, Fatih Haşlak, Sezgin Şahin, Oya Köker, Aybüke Günalp, Kenan Barut, Özgür Kasapçopur
DOI: 10.46497/ArchRheumatol.2023.9636
Unmet needs in psoriatic arthritis, a narrative review
Clementina Lopez-Medina, Umut Kalyoncu, Laure Gossec
DOI: 10.46497/ArchRheumatol.2024.10710
New and future perspectives in Behçet's syndrome
Bercemhan Sulu, Gulen Hatemi
DOI: 10.46497/ArchRheumatol.2024.11049
Lung involvement is a risk factor for treatment resistance in patients with polymyositis and dermatomyositis
Elif Altunel Kılınç, Bengisu Ece Duman, Süleyman Özbek
DOI: 10.46497/ArchRheumatol.2025.10989
Treatment of Systemic Sclerosis-Associated Interstitial Lung Disease: A Systematic Review and Network Meta-Analysis
Siyao Wu, Wanling Xu, Zhen Bei, Junpei Wu, Mingchun Zhang
DOI: 10.5152/ArchRheumatol.2025.25013